X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs PFIZER - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. PFIZER WOCKHARDT LTD./
PFIZER
 
P/E (TTM) x -18.8 28.7 - View Chart
P/BV x 3.1 4.6 67.7% View Chart
Dividend Yield % 1.1 0.7 150.3%  

Financials

 WOCKHARDT LTD.   PFIZER
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
PFIZER
Mar-16
WOCKHARDT LTD./
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,1292,724 41.4%   
Low Rs6271,611 38.9%   
Sales per share (Unadj.) Rs363.1440.9 82.4%  
Earnings per share (Unadj.) Rs-20.448.7 -42.0%  
Cash flow per share (Unadj.) Rs-7.075.8 -9.2%  
Dividends per share (Unadj.) Rs10.0015.00 66.7%  
Dividend yield (eoy) %1.10.7 164.6%  
Book value per share (Unadj.) Rs301.8462.9 65.2%  
Shares outstanding (eoy) m110.5545.75 241.6%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.44.9 49.2%   
Avg P/E ratio x-42.944.5 -96.5%  
P/CF ratio (eoy) x-125.928.6 -440.0%  
Price / Book Value ratio x2.94.7 62.1%  
Dividend payout %-48.930.8 -158.8%   
Avg Mkt Cap Rs m97,06399,163 97.9%   
No. of employees `0006.82.9 234.3%   
Total wages/salary Rs m9,6652,758 350.5%   
Avg. sales/employee Rs Th5,931.86,981.7 85.0%   
Avg. wages/employee Rs Th1,428.1954.5 149.6%   
Avg. net profit/employee Rs Th-334.0771.1 -43.3%   
INCOME DATA
Net Sales Rs m40,14620,170 199.0%  
Other income Rs m1,143857 133.3%   
Total revenues Rs m41,28921,028 196.4%   
Gross profit Rs m1284,310 3.0%  
Depreciation Rs m1,4891,239 120.2%   
Interest Rs m2,2535 43,321.2%   
Profit before tax Rs m-2,4723,923 -63.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m-2111,794 -11.8%   
Profit after tax Rs m-2,2602,228 -101.5%  
Gross profit margin %0.321.4 1.5%  
Effective tax rate %8.545.7 18.7%   
Net profit margin %-5.611.0 -51.0%  
BALANCE SHEET DATA
Current assets Rs m46,16016,299 283.2%   
Current liabilities Rs m19,2587,594 253.6%   
Net working cap to sales %67.043.2 155.3%  
Current ratio x2.42.1 111.7%  
Inventory Days Days10165 154.3%  
Debtors Days Days9426 365.2%  
Net fixed assets Rs m40,1658,622 465.8%   
Share capital Rs m553458 120.8%   
"Free" reserves Rs m32,81420,722 158.4%   
Net worth Rs m33,36721,180 157.5%   
Long term debt Rs m31,90325 127,610.8%   
Total assets Rs m89,68729,137 307.8%  
Interest coverage x-0.1755.5 -0.0%   
Debt to equity ratio x1.00 81,001.5%  
Sales to assets ratio x0.40.7 64.7%   
Return on assets %07.7 -0.1%  
Return on equity %-6.810.5 -64.4%  
Return on capital %-0.319.0 -1.8%  
Exports to sales %00.1 0.0%   
Imports to sales %017.5 0.0%   
Exports (fob) Rs mNA12 0.0%   
Imports (cif) Rs mNA3,526 0.0%   
Fx inflow Rs m9,12152 17,658.9%   
Fx outflow Rs m2,133140 1,523.9%   
Net fx Rs m6,988-88 -7,910.8%   
CASH FLOW
From Operations Rs m-2,6953,436 -78.4%  
From Investments Rs m-6,863-6,991 98.2%  
From Financial Activity Rs m12,545-619 -2,027.3%  
Net Cashflow Rs m3,010-4,174 -72.1%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 2.3 7.5 30.7%  
FIIs % 7.7 4.9 157.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 23.7 65.0%  
Shareholders   67,757 85,207 79.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   MERCK LTD  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jan 23, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS